Changing human DNA brings hope for treating diseases but raises concerns such as equitable access

We need rules before we let the genome-editing genie out of the bottle


The writer is a science commentator
Every emerging technology has its dreamers and schemers. That is certainly true of human genome editing, the focus of a high-profile global summit held this week at the Francis Crick Institute in London.
This story originally appeared on: Financial Times - Author:Anjana Ahuja